‌

US Patent 10793535 Heterocyclic glutaminase inhibitors

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Calithera Biosciences

Current Assignee

Calithera Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

October 6, 2020

Patent Application Number

14081175

Date Filed

November 15, 2013

Patent Citations

US Patent 10316030 Crystal forms of glutaminase inhibitors

US Patent 10258619 Combination therapy with glutaminase inhibitors and immuno-oncology agents

US Patent 10278968 Combination therapy with glutaminase inhibitors

US Patent 10441587 Treatment of lung cancer with inhibitors of glutaminase

Patent Citations Received

US Patent 10940148 Combination therapy with glutaminase inhibitors and immuno-oncology agents

Patent Primary Examiner

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10793535 Heterocyclic glutaminase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.